Israel Active

Just before 3:00 a.m., a 56-year-old mother suffered a heart attack at her Jerusalem home. A total of eight United Hatzalah volunteer EMTs ran up five floors to administer CPR and defibrillator shocks. After 12 minutes, the woman’s pulse returned, and she opened her eyes.

Scientists at Tel Aviv University’s Blavatnik Center (see ) are racing to find a cure for 2-year-old Eli Reich from New York, who suffers from the rare FOXG1 syndrome that damages brain development. They have already identified several FDA-approved medications that could repair Eli’s faulty FOXG1 proteins.

Thirty million feeding tubes are inserted into patients annually. One million are inserted incorrectly, many with tragic consequences. The ENVue electromagnetic wave-guided system from Israel’s Envizion prevents those mistakes. Its use is mandatory at many US hospitals.

Israel’s Brain.Q (reported May 2018) reported that the double-blind trial of its AI-based electromagnetic therapy shows that patients recovered 77% faster from the disabilities caused by the stroke and were able to resume normal life. The therapy now has FDA Breakthrough Device Designation.

A study of 500 cancer patients at Tel Aviv’s Sourasky (Ichilov) Medical Center found that those who took cannabis prior to oxaliplatin chemotherapy suffered 40% less nerve damage than those who didn’t. Oxaliplatin’s neurological side effects affect 70% of cancer patients.

Israel’s Cortica (reported previously) has launched another medical spinoff – CORDiguide. It is developing AI-based technology to navigate catheters, using angiographic imaging, to transport miniature treatment devices to a cancer target, along a road map of blood vessels.

A joint team from Israel’s Leumit Health Services, Bar-Ilan University, and Barzilai Medical Center analyzed records of over 10,000 Leumit patients. They found low-dose aspirin (75mg) reduced Covid-19 infection risk by 29% and shortened virus duration by about two days.

Albert Bourla, CEO of Pfizer explains why he chose Israel as the priority destination for his company’s SARS-COV-2 vaccine.  A small population, a good healthcare system, a high degree of electronic data and an obsessive Prime Minister. And the scientific partnership has a great future.

Israel’s five millionth recipient of the Covid-19 vaccine was a pregnant 34-year-old from the Tel Aviv suburb of Petah Tikva, Restaurants, cafes, attractions, hotels, event venues, places of worship, most school grades 7-10, and more, have opened. Only 3% of serious Covid-19 cases had received a 2nd shot.

Hebrew University researchers have developed a chip containing human tissue with microscopic sensors to precisely monitor the response of the kidney, liver and heart to specific treatments. It is believed to be the first treatment to be submitted to the US FDA for human trials without animal testing.